A new French case report shines a spotlight on a little-known potential complication of mesothelioma immunotherapy: celiac disease. Celiac disease is a chronic digestive and immune disorder brought on by sensitivity to gluten. Over time, celiac disease damages the small intestine causing long-lasting digestive problems. It can prevent patients from getting the nutrients they need to stay healthy. The new case report appears in Frontiers in Immunology. It details the case of a 70-year-old man who developed celiac disease after treatment with nivolumab. The case suggests that celiac disease may be an underrecognized side effect of mesothelioma immunotherapy. It is a reminder for mesothelioma patients and doctors to pay close attention to digestive problems after treatment. Stimulating the Immune System … Continue reading Celiac Disease May Be a Little-Known Complication of Mesothelioma Immunotherapy
New research suggests that chemoperfusion treatment for mesothelioma may buy patients more time without the side effects of traditional chemotherapy. Chemoperfusion treatment involves injecting cancer-killing drugs directly into the vessels that feed a pleural mesothelioma tumor. The research was presented during a virtual session of the Society of Interventional Radiology’s annual meeting. Researchers showed how this novel approach could improve quality of life for mesothelioma patients. Limitations of Chemotherapy Pleural mesothelioma is a rare cancer with few treatment options. Most mesothelioma patients start with chemotherapy. Alimta (pemetrexed) is the primary chemotherapy drug for mesothelioma. But chemotherapy has drawbacks that chemoperfusion treatment for mesothelioma might avoid. Conventional chemotherapy circulates drugs throughout the body. That means that normal cells can absorb them … Continue reading Chemoperfusion Treatment for Mesothelioma: Chemo Without the Side Effects?